Search

everythinglearnresearchcommunity

for

Search:↓

Topical eye β-blockers may cause hair loss.

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

Copper deficiency may cause hair loss, and treating it could involve nutrition and hormones.

Human hair follicles switch between active and resting phases unpredictably.

Finasteride and flutamide effectively reduce hirsutism in PCOS women, with flutamide also lowering hormone levels.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Aldactone was more effective in reducing hair growth in women with hirsutism than Diane, despite having less impact on hormone levels.

Patients with myotonic dystrophy often have skin problems that suggest early aging and vitamin D issues, and the severity of these problems is linked to their genetic condition and vitamin D levels.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

PCOS is linked to low-grade chronic inflammation.

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.

Integrin alphavbeta6 is important for wound healing and hair growth, and blocking it may improve these processes.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Ectodin integrates BMP, SHH, and FGF signals in developing ectodermal organs.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Estrogen Receptor ß (ERß) is the main hormone controller in human skin and hair follicles, not Estrogen Receptor α (ERα) or the Androgen Receptor (AR).

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

Hair sensitivity to androgens is partly controlled by specific enzyme expressions in different hair areas.

Lifestyle changes and weight loss are key for treating PCOS-related metabolic issues and infertility, with various medications available for specific symptoms.

Continuous light exposure in rats leads to PCOS-like symptoms and suggests sleep habits might affect the disorder's development.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

The research found that MRI and certain hormone levels can help tell apart ovarian tumors from hyperthecosis in postmenopausal women, but tissue analysis is still needed for a definite diagnosis.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

Genes linked to fibrosis are more active in people with central centrifugal cicatricial alopecia.

PCOS may start before birth, involves metabolic issues, and can be treated with drugs like metformin and lifestyle changes.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.